Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Oncotarget
|
May 31, 2018
Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma
Toshima Z Parris, Elisabeth Werner Rönnerman, Hanna Engqvist, et al.
Scientific Reports
|
October 23, 2025
Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer
Ella Ittner, Hugo Swenson, Lucas Werner, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Effects of Recombinant α<sub>1</sub>-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to <sup>177</sup>Lu-Octreotate
Charlotte Ytterbrink, Emman Shubbar, Toshima Z Parris, et al.
Molecular Therapy. Oncology
|
February 13, 2025
Attenuated titin protein expression is associated with advanced stages of ovarian cancer
Harvey Sharma, Jaskaran Aujla, Asad Nawaz, et al.
Scientific Reports
|
August 13, 2024
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties
Peter Larsson, Maria Cristina De Rosa, Benedetta Righino, et al.
EJNMMI Research
|
January 19, 2017
Priming increases the anti-tumor effect and therapeutic window of <sup>177</sup>Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1
Johanna Dalmo, Johan Spetz, Mikael Montelius, et al.
Cell Death Discovery
|
January 29, 2024
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
Peter Larsson, Daniella Pettersson, Maxim Olsson, et al.
Journal of Ovarian Research
|
May 19, 2025
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma
Hugo Swenson, Ella Ittner, Lucas Werner, et al.
Molecular Therapy. Oncology
|
September 18, 2024
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer
Ghassan M Saed, Nicole M Fletcher, Harvey Sharma, et al.
Molecular Therapy. Oncology
|
August 8, 2025
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics
Lucas Werner, Ella Ittner, Hugo Swenson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Oncotarget
|
May 31, 2018
Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma
Toshima Z Parris, Elisabeth Werner Rönnerman, Hanna Engqvist, et al.
Scientific Reports
|
October 23, 2025
Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer
Ella Ittner, Hugo Swenson, Lucas Werner, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Effects of Recombinant α<sub>1</sub>-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to <sup>177</sup>Lu-Octreotate
Charlotte Ytterbrink, Emman Shubbar, Toshima Z Parris, et al.
Molecular Therapy. Oncology
|
February 13, 2025
Attenuated titin protein expression is associated with advanced stages of ovarian cancer
Harvey Sharma, Jaskaran Aujla, Asad Nawaz, et al.
Scientific Reports
|
August 13, 2024
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties
Peter Larsson, Maria Cristina De Rosa, Benedetta Righino, et al.
EJNMMI Research
|
January 19, 2017
Priming increases the anti-tumor effect and therapeutic window of <sup>177</sup>Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1
Johanna Dalmo, Johan Spetz, Mikael Montelius, et al.
Cell Death Discovery
|
January 29, 2024
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer
Peter Larsson, Daniella Pettersson, Maxim Olsson, et al.
Journal of Ovarian Research
|
May 19, 2025
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma
Hugo Swenson, Ella Ittner, Lucas Werner, et al.
Molecular Therapy. Oncology
|
September 18, 2024
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer
Ghassan M Saed, Nicole M Fletcher, Harvey Sharma, et al.
Molecular Therapy. Oncology
|
August 8, 2025
Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics
Lucas Werner, Ella Ittner, Hugo Swenson, et al.
Page
of 8